One of the leading pharmaceutical companies established in 1974 in Ankara Turkey as a member of the Nevzat Group of Companies founded by the Group president Mr. Nevzat Karpuzcu (B.Pharm). The Nevzat Group constitutes of 3 companies namely Drogsan Pharmaceuticals, Nevzat Pharma Wholesale founded in 1962 and Prestij Pharma Wholesale founded in 1994.
Nevzat Pharma Wholesale is the second pharma wholesale group and the third largest pharma wholesale in Turkey established on a 5000 m2 area. It has 6 branches and 15 distribution offices scattered all over Turkey and employs over 950 staff along its specialized tender team that covers all the pharma tenders in Turkey.
Prestij Pharma Wholesale specializes in the distribution of imported pharmaceuticals in Turkey and ranks as one of the three largest import pharma wholesale group in Turkey and employs over 50 staff. It has 3 distribution offices in Ankara.
Nevzat Pharma Wholesale, Prestij Pharma Wholesale and Drogsan Pharmaceuticals headquarters are all located in the same building in Balgat, Ankara.
Drogsan Pharmaceuticals is an ISO 9000-2001 accredited, technologically modern pharmaceutical company with well established Manufacturing, Warehousing, In-house R&D, Regulatory Affairs, Marketing & Sales, Distribution, Licensing in and Export facilities. Drogsan’s vision is to become a research based international pharmaceutical company through its mission to provide healthcare professionals with innovative, quality products to attain common goal of a healthier future. Drogsan strictly complies to cGMP & GLP regulations as its principle quality policy.
The production plant already accredited by the Turkish Ministry of Health and 16 other recognized regulatory authorities in 16 different countries is established on a 16,500 M2 area with manufacturing facilities as per the current GMP and GLP regulations. Inspection and accreditation of the facilities by EU authorities is planned to be conducted in the 3rd quarter of 2008.
Drogsan’s Sales and Marketing team of 260 active field sales force is coordinated by product managers and regional sales managers. The team is geographically strategically located in 15 principle regions of Turkey from where it is able to access and market Drogsan’s products to the whole of the Turkish pharmaceutical market.
The In-house R&D Department specializes in value added pharmaceutical development and novel drug delivery systems. The Regulatory Department works in close coordination with the R&D department and is able to prepare CTD dossiers conforming to the current EU standards and regulations. As such, Drogsan is currently licensing out its products to some European countries.
Drogsan actively exports its products1 to 11 countries, with its products undergoing registration procedures in 5 other countries. Drogsan is currently looking for potential partners in Europe, Western Europe, Scandinavia, Russia and South America.
Active Export Countries:
Azerbaijan, Ghana, Georgia, Hong Kong, Jordan, Malaysia, Moldova, Nigeria, Vietnam, Uzbekistan, Yemen
Under Registration:
Bulgaria, Kazakhstan, Myanmar UAE, Ukraine.
Drogsan provides a modern, settled organization for international companies who do not have necessary resources to enter Turkey and surrounding niche markets which are unique in terms of culture, language and differing regulatory procedures in its quest for bringing new molecules and and technology to Turkey and surrounding countries.
Drogsan is currently looking for foreign partners ready to license out novel oncology, cardiology, antibiotics and asthmatic pharmaceutical products in Turkey.
| 
